On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.
The committee that is responsible for reviewing applications for orphan designation for medicines that are intended for the diagnosis, prevention or treatment of rare diseases. Abbreviated as COMP.
More information can be found under 'Committee for Orphan Medicinal Products (COMP)'.